Genmab — Juni 2016
-
kommer tid, kommer råd. Vi ved jo ret beset ikke meget, før vi ser data på programmet
-
...i det hele taget har vi hørt meget, men set meget lidt til potentialet i duobody
-
Isatuximab (SAR650984) fase 2 monoterapi var på ASCO som oral præsentation. Abstract: http://meetinglibrary.asco.org/content/163734-176 Omtale på Myeloma Beacon http://www.myelomabeacon.com/news/2016/06/06/asco-2016-multiple-myeloma-update-days-one-two-three/ ORR og PFS en bønne dårligere end Sirius. Men Beacon konkluderer: Based on these results and the updated results for isatuximab presented by Dr. Richter, it appears that isatuximab has anti-myeloma activity comparable to that of Darzalex.
-
hhmm skulle man købe nogle Sanofi aktier?
-
"
It is interesting data, but I don't know if this is necessarily going to change treatment decisions" -
sagt af " Sagar Lonial, MD, of the Winship Cancer Center at Emory University in Atlanta"
-
...men det har jo altid været Sanofis cd38, der har været den store konkurrent
-
men hvis Isatuximab kan vise data der er sammenlignelige med Darzalex.
-
Nu har Sanofi et market cap på 92bn EUR. Så Isatuximab vil ikke har så meget effect. Og på diabetes blev de kørt over af Novo. Så ideen med Sanofi aktier er allerede droppet.
-
Seeking Alpha artikel http://seekingalpha.com/article/3980412-darzalex-tries-climb-myeloma-ladder
-
hej. vedr ROI´s analyse. er der nogle som allerede har google trans denne ? (det har der været tidligere) ?
-
Farma&French - tusind tak for den artikel. Monster interessant omkring pricing
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind